Unknown file type. Enclosure URL IS: - http://www.biotech-now.org/wp-content/uploads/2012/12/Inside-the-NBI-composition-and-performance-1Q-20122.pdf
Summary: The broader biotech indices are up more than 30 percent this year and have reached levels not seen since the peak of March 2000. Larger biotechs account for much of the index returns, as we have described previously, and have helped the sector outperform the S&P 500 by two fold. But how have smaller biotech companies been performing? As of Nov 30, 27 companies that started the year under $1 billion in market capitalization have Read More
